| Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810. Journal of clinical oncology : official journal of the American Society of Clinical Oncology | LJ Appleman, SE Kim, WB Harris, SK Pal, MR Pins, J Kolesar, N Agarwal, RA Parikh, DA Vaena, CW Ryan, M Hashmi, BA Costello, D Cella, JP Dutcher, RS DiPaola, NB Haas, LI Wagner, MA Carducci | 03/26/2024 |
| Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience. Journal of immunotherapy and precision oncology | DJ Martini, TA Olsen, S Goyal, Y Liu, ST Evans, EE Hitron, GA Russler, L Yantorni, S Caulfield, JT Brown, JM Goldman, B Nazha, BC Carthon, WB Harris, O Kucuk, VA Master, MA Bilen | 08/01/2022 |
| Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials. Cancers | TZ Zhuang, K Case, TA Olsen, JT Brown, BC Carthon, O Kucuk, J Goldman, W Harris, MA Bilen, B Nazha | 06/10/2022 |
| Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients. Clinical genitourinary cancer | DJ Martini, ST Evans, Y Liu, JM Shabto, OE Uner, TA Olsen, JT Brown, GA Russler, L Yantorni, S Caulfield, JM Goldman, B Nazha, WB Harris, VA Master, O Kucuk, BC Carthon, MA Bilen | 02/01/2022 |
| Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy. Frontiers in endocrinology | TA Olsen, TZ Zhuang, S Caulfield, DJ Martini, JT Brown, BC Carthon, O Kucuk, W Harris, MA Bilen, B Nazha | 01/01/2022 |
| Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors. The oncologist | DJ Martini, JM Shabto, S Goyal, Y Liu, TA Olsen, ST Evans, BL Magod, D Ravindranathan, JT Brown, L Yantorni, GA Russler, S Caulfield, JM Goldman, B Nazha, SS Joshi, HT Kissick, KE Ogan, WB Harris, O Kucuk, BC Carthon, VA Master, MA Bilen | 12/01/2021 |
| Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. The oncologist | DJ Martini, S Goyal, Y Liu, ST Evans, TA Olsen, K Case, BL Magod, JT Brown, L Yantorni, GA Russler, S Caulfield, JM Goldman, B Nazha, WB Harris, HT Kissick, VA Master, O Kucuk, BC Carthon, MA Bilen | 10/01/2021 |
| Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors. Journal for immunotherapy of cancer | JT Brown, Y Liu, JM Shabto, D Martini, D Ravindranathan, EE Hitron, GA Russler, S Caulfield, L Yantorni, SS Joshi, H Kissick, K Ogan, B Nazha, BC Carthon, O Kucuk, WB Harris, VA Master, MA Bilen | 07/01/2021 |
| Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors. The oncologist | JT Brown, Y Liu, JM Shabto, DJ Martini, D Ravindranathan, EE Hitron, GA Russler, S Caulfield, LB Yantorni, SS Joshi, H Kissick, K Ogan, WB Harris, BC Carthon, O Kucuk, VA Master, MA Bilen | 05/01/2021 |
| Stroke-Induced Peripheral Immune Dysfunction in Vitamin D-Deficient Conditions: Modulation by Progesterone and Vitamin D. Molecular neurobiology | S Yousuf, F Atif, C Espinosa-Garcia, W Harris, N Turan, DG Stein | 03/01/2021 |
| Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib. Cancer treatment and research communications | DJ Martini, MR Kline, Y Liu, JM Shabto, BC Carthon, GA Russler, L Yantorni, EE Hitron, S Caulfield, JM Goldman, WB Harris, O Kucuk, VA Master, MA Bilen | 01/01/2021 |
| Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors. Frontiers in oncology | DJ Martini, TA Olsen, S Goyal, Y Liu, ST Evans, B Magod, JT Brown, L Yantorni, GA Russler, S Caulfield, JM Goldman, B Nazha, HT Kissick, WB Harris, O Kucuk, BC Carthon, VA Master, MA Bilen | 01/01/2021 |
| Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade. Frontiers in oncology | TA Olsen, DJ Martini, S Goyal, Y Liu, ST Evans, B Magod, JT Brown, L Yantorni, GA Russler, S Caulfield, JM Goldman, WB Harris, O Kucuk, BC Carthon, VA Master, B Nazha, MA Bilen | 01/01/2021 |
| Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma. British journal of cancer | RD Harvey, BC Carthon, C Lewis, MS Hossain, C Zhang, Z Chen, WB Harris, OB Alese, W Shaib, MA Bilen, DH Lawson, C Wu, CE Steuer, BF El-Rayes, FR Khuri, S Lonial, EK Waller, SS Ramalingam, TK Owonikoko | 10/01/2020 |
| A Phase I Study of Safety, Pharmaco*kinetics, and Pharmacodynamics of Concurrent Everolimus and Buparlisib Treatment in Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research | TK Owonikoko, RD Harvey, B Carthon, Z Chen, C Lewis, H Collins, C Zhang, DH Lawson, OB Alese, MA Bilen, GL Sica, CE Steuer, WL Shaib, C Wu, WB Harris, M Akce, RR Kudchagkar, BF El-Rayes, S Lonial, SS Ramalingam, FR Khuri | 06/01/2020 |
| Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors. Cancer medicine | JM Shabto, DJ Martini, Y Liu, D Ravindranathan, J Brown, EE Hitron, GA Russler, S Caulfield, H Kissick, M Alemozaffar, K Ogan, WB Harris, VA Master, O Kucuk, BC Carthon, MA Bilen | 04/01/2020 |
| Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. The oncologist | DJ Martini, Y Liu, JM Shabto, BC Carthon, EE Hitron, GA Russler, S Caulfield, HT Kissick, WB Harris, O Kucuk, VA Master, MA Bilen | 03/01/2020 |
| Chemokine receptor 4 targeted protein MRI contrast agent for early detection of liver metastases. Science advances | S Tan, H Yang, S Xue, J Qiao, M Salarian, K Hekmatyar, Y Meng, R Mukkavilli, F Pu, OY Odubade, W Harris, Y Hai, ML Yushak, VM Morales-Tirado, P Mittal, PZ Sun, D Lawson, HE Grossniklaus, JJ Yang | 02/01/2020 |
| Association Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Outcome of Patients With Metastatic Renal-Cell Carcinoma Treated With Nivolumab. Clinical genitourinary cancer | MA Bilen, GMA Dutcher, Y Liu, D Ravindranathan, HT Kissick, BC Carthon, O Kucuk, WB Harris, VA Master | 06/01/2018 |
| A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma. Asian journal of urology | RR Sekar, D Patil, Y Baum, J Pearl, A Bausum, MA Bilen, O Kucuk, WB Harris, BC Carthon, M Alemozaffar, CP Filson, JG Pattaras, PT Nieh, K Ogan, VA Master | 10/01/2017 |
| Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype. Oncogene | X Guo, JL Koff, AB Moffitt, M Cinar, S Ramachandiran, Z Chen, JM Switchenko, M Mosunjac, SG Neill, KP Mann, M Bagirov, Y Du, Y Natkunam, HJ Khoury, MR Rossi, W Harris, CR Flowers, IS Lossos, LH Boise, SS Dave, J Kowalski, L Bernal-Mizrachi | 07/20/2017 |
| Time-dependent effects of prognostic biomarkers of systemic inflammation in patients with metastatic renal cell carcinoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine | WB Harris, C Zhang, Y Liu, DK Robertson, MY Akbashev, BM Lingerfelt, O Kucuk, BC Carthon, TW Gillespie, AO Osunkoya, VA Master | 06/01/2017 |
| Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors. Bone marrow transplantation | Z DeFilipp, CB Rosand, DA Goldstein, VA Master, BC Carthon, WB Harris, O Kucuk, Z Al-Kadhimi, JB Cohen, CR Flowers, MJ Lechowicz, AK Nooka, JL Kaufman, AA Langston, Z Chen, J Arora, EK Waller | 01/01/2017 |
| Monitoring the kinetics of B-cell recovery following rituximab may guide the management of steroid-refractory chronic GvHD. Bone marrow transplantation | Z DeFilipp, M Purcell, WA Harris, DJ Chandra, C Gleason, J Wrammert, S Sarantopoulos, EK Waller | 04/01/2016 |
| The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism. Oncotarget | H Yang, CM Brackett, VM Morales-Tirado, Z Li, Q Zhang, MW Wilson, C Benjamin, W Harris, EK Waller, AV Gudkov, LG Burdelya, HE Grossniklaus | 01/19/2016 |
| Biomarkers for evaluating racial disparities in clinical outcome in patients with renal cell carcinoma. Molecular aspects of medicine | WB Harris | 11/01/2015 |
| C-reactive protein in urologic cancers. Molecular aspects of medicine | J Huang, Y Baum, M Alemozaffar, K Ogan, W Harris, O Kucuk, VA Master | 11/01/2015 |
| Lycopene in the prevention of renal cell cancer in the TSC2 mutant Eker rat model. Archives of biochemistry and biophysics | K Sahin, B Cross, N Sahin, K Ciccone, S Suleiman, AO Osunkoya, V Master, W Harris, B Carthon, R Mohammad, B Bilir, K Wertz, CS Moreno, CL Walker, O Kucuk | 04/15/2015 |
| External validation of the modified Glasgow prognostic score for renal cancer. Indian journal of urology : IJU : journal of the Urological Society of India | CG Tai, TV Johnson, A Abbasi, L Herrell, WB Harris, O Kucuk, DJ Canter, K Ogan, JG Pattaras, PT Nieh, VA Master | 01/01/2014 |
| Properties of immature myeloid progenitors with nitric-oxide-dependent immunosuppressive activity isolated from bone marrow of tumor-free mice. PloS one | P Forghani, W Harris, CR Giver, A Mirshafiey, J Galipeau, EK Waller | 01/01/2013 |
| Lectins identify glycan biomarkers on glioblastoma-derived cancer stem cells. Stem cells and development | C Tucker-Burden, P Chappa, M Krishnamoorthy, BA Gerwe, CD Scharer, J Heimburg-Molinaro, W Harris, SN Usta, CD Eilertson, CG Hadjipanayis, SL Stice, DJ Brat, RJ Nash | 09/01/2012 |
| Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy. International journal of surgical oncology | BW Cross, TV Johnson, AB Derosa, K Ogan, JG Pattaras, PT Nieh, O Kucuk, WB Harris, VA Master | 01/01/2012 |
| Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma. The Journal of urology | TV Johnson, S Ali, A Abbasi, O Kucuk, WB Harris, K Ogan, J Pattaras, PT Nieh, FF Marshall, AO Osunkoya, VA Master | 10/01/2011 |
| Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice. Journal of immunology (Baltimore, Md. : 1950) | JM Li, L Southerland, MS Hossain, CR Giver, Y Wang, K Darlak, W Harris, J Waschek, EK Waller | 07/15/2011 |
| Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patients. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine | S Ali, Q Yin-Goen, TV Johnson, W Han, NA Johnson, WB Harris, FF Marshall, AN Young, VA Master, AO Osunkoya | 04/01/2011 |
| Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma. Urology | TV Johnson, A Abbasi, A Owen-Smith, AN Young, O Kucuk, WB Harris, AO Osunkoya, K Ogan, J Pattaras, PT Nieh, FF Marshall, VA Master | 09/01/2010 |
| Activation, immune polarization, and graft-versus-leukemia activity of donor T cells are regulated by specific subsets of donor bone marrow antigen-presenting cells in allogeneic hemopoietic stem cell transplantation. Journal of immunology (Baltimore, Md. : 1950) | JM Li, LT Southerland, Y Lu, KA Darlak, CR Giver, DW McMillin, WA Harris, DL Jaye, EK Waller | 12/15/2009 |
| Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease. American heart journal | V Subramaniyam, EK Waller, JR Murrow, A Manatunga, S Lonial, K Kasirajan, D Sutcliffe, W Harris, WR Taylor, RW Alexander, AA Quyyumi | 07/01/2009 |
| Regulation of alloimmune responses by dendritic cell subsets. Experimental hematology | S Lonial, C Torre, E David, W Harris, M Arellano, EK Waller | 10/01/2008 |
| Sleep/Wake patterns of individuals with advanced cancer measured by ambulatory polysomnography. Journal of clinical oncology : official journal of the American Society of Clinical Oncology | KP Parker, DL Bliwise, M Ribeiro, SR Jain, CI Vena, MK Kohles-Baker, A Rogatko, Z Xu, WB Harris | 05/20/2008 |
